Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 7 results for "olopatadine"

Anti-allergic agent alcaftadine stronger in relief of ocular i...

Take home In head-to-head clinical assessments, alcaftadine was found to be statistically and clinically superior to olopatadine for relief of allergic conjunctivitis. By Eugene B. McLaurin, MD, Special to Ophthalmology Times Memphis, ... Ophthalmology Times, 1 month ago

Salicylate Inhibits Thrombopoiesis in Rat Megakaryocytes by Changing the Membrane Micro-Architecture

Abstract Background/Aims: Salicylate causes drug-induced immune thrombocytopenia. However, some clinical studies indicate the presence of additional mechanisms in the drug-induced thrombocytopenia, by which the platelet production from ...
 Cellular Physiology and Biochemistry15 hours ago

Step-wise strategy addresses challenges of atopic keratoconjunctivitis

Take-Home Message: Pediatric patients with atopic keratoconjunctivitis affecting the eyes may best be treated with topical calcineurin inhibitors to decrease the conjunctival inflammation. By Lynda Charters; Reviewed by Stephen ...
 Ophthalmology Times2 days ago

Weathering the allergic conjunctivitis storm

Allergic cascade Source: Richard L. Lindstrom, MD Understanding the umbrella of treatments F or all too many, April is the time of year when ocular allergies are brewing. Such allergies are common, said Richard L. Lindstrom, MD, ...
 Eye World2 days ago Clinical Advances in Ocular Allergy  Review of Ophthalmology2 days ago

Sampling New Targets for Allergy Therapy

The hunt for new therapeutics is daunting. Beyond the initial matchmaking of drug candidate and cellular target comes a string of hurdles—some sequential and many parallel—that include preclinical testing, formulation, manufacturing, stability, ...
 Review of Ophthalmology1 month ago

Alcon's Pazeo allergy drop available March 10

ATLANTA Alcon's new once daily Pazeo will be commercially available March 10, announced a company representative during a press conference here at SECO . Mike Burns, U.S. allergy brand manager for Alcon, said that Pazeo (olopatadine HCl ...
 Orthopedics Today1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less